Adams, Thomas <br/><br/>
Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.  [electronic resource] 

 -  Cancer genetics  04 2018 
 - 25-31 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>2210-7762 
<br/><br/><label>Standard No.: </label>10.1016/j.cancergen.2018.01.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chromosome Inversion<br/>Chromosomes, Human, Pair 18--genetics<br/>Chromosomes, Human, Pair 3--genetics<br/>Cyclophosphamide--therapeutic use<br/>Doxorubicin--therapeutic use<br/>Etoposide--therapeutic use<br/>Female<br/>Gene Expression Profiling<br/>Gene Order<br/>Genes, myc<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Lymphoma, B-Cell--drug therapy<br/>MDS1 and EVI1 Complex Locus Protein--genetics<br/>Middle Aged<br/>Neoplasm Grading<br/>Prednisone--therapeutic use<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>Proto-Oncogene Proteins c-bcl-6--genetics<br/>Proto-Oncogene Proteins c-myc--genetics<br/>Remission Induction<br/>Sequence Analysis, RNA<br/>Translocation, Genetic<br/>Treatment Outcome<br/>Vincristine--therapeutic use